|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to newborn screening for congenital heart defects. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. The heading to Chapter 33, Health and Safety |
|
Code, is amended to read as follows: |
|
CHAPTER 33. PHENYLKETONURIA, OTHER HERITABLE DISEASES, |
|
HYPOTHYROIDISM, CONGENITAL HEART DEFECTS, AND CERTAIN OTHER |
|
DISORDERS |
|
SECTION 2. Section 33.001, Health and Safety Code, is |
|
amended by amending Subdivision (1) and adding Subdivisions (1-a) |
|
and (4-a) to read as follows: |
|
(1) "Congenital heart defect" means a structural |
|
abnormality of the heart that is present at birth. |
|
(1-a) "Heritable disease" means an inherited disease |
|
that may result in mental or physical retardation or death. |
|
(4-a) "Pulse oximetry screening test" means a |
|
noninvasive test that estimates the percentage of hemoglobin in |
|
blood that is saturated with oxygen. |
|
SECTION 3. Sections 33.002(a) and (c), Health and Safety |
|
Code, are amended to read as follows: |
|
(a) The department shall carry out a program to combat |
|
morbidity, including mental retardation, and mortality in persons |
|
who have phenylketonuria, other heritable diseases, [or] |
|
hypothyroidism, or congenital heart defects. |
|
(c) The department shall establish and maintain a |
|
laboratory to: |
|
(1) conduct experiments, projects, and other |
|
activities necessary to develop screening or diagnostic tests for |
|
the early detection of phenylketonuria, other heritable diseases, |
|
[and] hypothyroidism, and congenital heart defects; |
|
(2) develop ways and means or discover methods to be |
|
used to prevent or treat phenylketonuria, other heritable diseases, |
|
[and] hypothyroidism, and congenital heart defects; and |
|
(3) serve other purposes considered necessary by the |
|
department to carry out the program. |
|
SECTION 4. Section 33.011, Health and Safety Code, is |
|
amended by amending Subsections (a) and (c) and adding Subsection |
|
(d) to read as follows: |
|
(a) The physician attending a newborn child or the person |
|
attending the delivery of a newborn child that is not attended by a |
|
physician shall subject the child to: |
|
(1) screening tests approved by the department for |
|
phenylketonuria, other heritable diseases, hypothyroidism, and |
|
other disorders for which screening is required by the department; |
|
and |
|
(2) a pulse oximetry screening test for congenital |
|
heart defects if the child is attended by the physician or person at |
|
a birthing facility. |
|
(c) Except for the pulse oximetry screening test required by |
|
Subsection (a)(2), the [The] screening tests required by this |
|
section must be performed by the laboratory established by the |
|
department or by a laboratory approved by the department under |
|
Section 33.016. |
|
(d) In this section, "birthing facility" means an inpatient |
|
or ambulatory health care facility that offers obstetrical and |
|
newborn care services. The term includes: |
|
(1) a hospital licensed under Chapter 241 that offers |
|
obstetrical services; |
|
(2) a birthing center licensed under Chapter 244; |
|
(3) a children's hospital licensed by the department; |
|
or |
|
(4) a facility maintained and operated by the |
|
department. |
|
SECTION 5. As soon as practicable after the effective date |
|
of this Act, the Department of State Health Services shall |
|
implement the changes in law made by this Act to the newborn |
|
screening program under Chapter 33, Health and Safety Code. |
|
SECTION 6. This Act takes effect September 1, 2013. |